| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0012 | 1 |